Evolus, Inc. EOLS

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $9.06
Market Cap $596.64M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑11.6% YoY
$297.18M
3-Yr CAGR: 26.0%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↓-134.7% YoY
-$45.71M
FCF Yield: -7.66%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (EOLS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $-25.7M $-25.7M
FY 2019 $34.9M $26.9M $-93.4M $-93.7M -265.0%
FY 2020 $56.5M +61.9% $38.2M $-57.9M $-58.7M +37.4%
FY 2021 $99.7M +76.3% $56.1M $-33.4M $-33.8M +42.4%
FY 2022 $148.6M +49.1% $89.8M $-84.9M $-86.5M -156.1%
FY 2023 $202.1M +36.0% $140.5M $-34.0M $-34.5M +60.2%
FY 2024 $266.3M +31.8% $182.3M $-18.0M $-19.5M +43.5%
FY 2025 $297.2M +11.6% $197.1M $-42.3M $-45.7M -134.7%
$

Valuation

Market Price $9.06
Market Cap $596.64M
Enterprise Value $542.82M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -7.66%
Dividend Yield N/A
Shares Outstanding 65,854,800
%

Profitability & Margins

Gross Margin 66.33%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) N/A
Asset Turnover 1.32x
Revenue 3-Yr CAGR 25.98%
🛡️

Financial Health & Liquidity

Current Ratio 0.05
Cash Ratio 0.71
Debt / Equity -0.000
Debt / Assets 0.000
Cash & Equivalents $53.83M
Total Debt N/A
Book Value / Share $-0.35
💧

Cash Flow Efficiency

Operating Cash Flow -$42.27M
Capital Expenditures (CapEx) $3.44M
Free Cash Flow -$45.71M
OCF / Revenue -14.22%
FCF / Revenue -15.38%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.35
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $225.87M
Total Liabilities $248.97M
Stockholders' Equity -$23.11M
Current Assets $3.67M
Current Liabilities $75.31M